Latest filing published 14 Dec 2023 for XORTX Therapeutics Inc..
No signal scores available.
This profile gathers the share dealings of Paul Joseph Van Damme in XORTX Therapeutics Inc. The record holds 2 filings, for trades running from 24 September 2021 to 10 November 2023.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 14 December 2023, reports a transaction in XORTX Therapeutics Inc. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations